Spinal cord injury

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
14 Unique IMPs
1 Commercial trials
Drug classes (ATC)
N Neurology/Psychiatry (ATC N) 1
J Anti-infectives (ATC J) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 8 substances
Fluoroquinolone 3 substances
Triptan 1 substance
Penicillin 1 substance
Macrolide / aminoglycoside 1 substance
Phase III: 1 Phase I/II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Centre Hospitalier Universitaire De Nantes Academic
    AMOXICILLIN; AMOXICILLIN, CLAVULANIC ACID; AZTREONAM; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; FOSFOMYCIN TROMETAMOL; LEVOFLOXACIN; LIDOCAINE HYDROCHLORIDE MONOHYDRATE, CEFTRIAXONE; OFLOXACIN; PIVMECILLINAM HYDROCHLORIDE; SULFAMETHOXAZOLE, TRIMETHOPRIM; TRIMETHOPRIM
    2024-515107-19-00 1 country n=526
    Pending

Phase I/II

1 trial
  • Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A. Commercial
    ELETRIPTAN
    2023-509207-33-01 2 countries 2025 n=42
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A. Commercial 1 Phase I/II 1
Centre Hospitalier Universitaire De Nantes Academic 1 Phase III 0
New trials by year
2025
1
← All indication landscapes